<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Mouton, Johan W.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Preventing Resistance — The Role of Optimized Dosing</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">19-20</style></pages><abstract><style  face="normal" font="default" size="100%">The rapid emergence of antibiotic resistance is a major public health concern [Zhang L et al. Appl Environ Microbiol 2011]. This article discusses five questions of resistant bacteria in the gut: Their possible presence without antibiotic exposure; Whether there is selection of resistant gut bacteria during antimicrobial exposure; Whether there is selection of resistance during systemic treatment for other infections; Whether it is possible to avoid or minimize selection; How optimization of treatment relates to selection of resistance in the gut.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>